AI to help diagnose kidney disease from biopsy
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests an artificial intelligence system that helps doctors analyze kidney tissue samples. If you have chronic kidney disease and need a biopsy, this study will see if the AI can improve diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must have kidney disease or be suspected of having it
- You must be scheduled for a kidney biopsy
- The biopsy tissue must come from your own kidney, not a donated one
- The sample must be good enough for doctors to examine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if an artificial intelligence system can improve MRI scans used to detect prostate cancer. You may join if your doctor has recommended a prostate biopsy and you have an MRI scan that can be reviewed by both radiologists and AI.
This trial is testing an artificial intelligence (AI) system that helps doctors diagnose and treat urological conditions like urinary stones, prostate cancer, or bladder cancer. It looks at your medical records, scans, and surgical videos to improve care.
This trial tests if feedback from an AI system can help doctors and medical trainees improve their reasoning when solving kidney-related case scenarios. You participate online and get a chance to practice with real-world cases.
This study tests whether artificial intelligence (AI) can help doctors tell kidney tumors apart from non-cancerous growths using a regular CT scan without contrast dye. If the AI works well, it could help doctors make better decisions without the need for extra procedures.
This study uses artificial intelligence to help plan the best surgery for kidney tumors. You may be eligible if you have a kidney tumor that can be removed with surgery and have had a special CT scan within the past month.
This study uses artificial intelligence (AI) to predict if critically ill patients in the ICU will develop acute kidney injury (sudden kidney failure). It looks at your medical data to spot early signs and help doctors act faster.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.